Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Second Edition BOGP (0)
Allemagne (2)
Policy
Musculoskeletal/Multiple Sclerosis (MS) (1)
Private Public Partnership (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Roles and responsibilities
Clinical study phase I